Therapy News and Research

RSS

Digital cognitive behavioral therapy reduces blood sugar levels in patients with diabetes

People with Type 2 diabetes who were given a smartphone app that delivers personalized cognitive behavioral therapy (CBT) saw significantly greater reductions in their blood sugar and less need for higher doses of diabetes medications at six months compared with those who only received standard diabetes care and a control app, in a study presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.

24 Feb 2023

Exploring the immunomodulatory and anti-inflammatory properties of butyrate

In a recent study published in the journal Fermentation, researchers reviewed studies examining the role of butyrate in inflammatory responses, immunological properties, and diseases related to the immune system such as atopic dermatitis, systemic lupus erythematosus, human immunodeficiency virus (HIV), psoriasis, and cancer.

24 Feb 2023

A network of interacting proteins created to aid drug discovery

Scientists at Open Targets, EMBL's European Bioinformatics Institute, and GSK are revealing the shared basis of diseases using a map of interacting human proteins.

24 Feb 2023

Study of adult e-cigarette users' attempts and experiences of quitting

Many e-cigarette (vape) users intend to quit, but there are few evidence-based interventions to help them do so. Due to this lack of interventions for e-cigarette cessation, researchers in the United States studied how and why users attempt to quit independently. The study, published in the journal Environmental Research and Public Health, analyzed both barriers and facilitators to quitting e-cigarettes.

23 Feb 2023

Mystical and insightful psychedelic experience may be linked to positive mental health outcomes

A more mystical and insightful psychedelic drug experience may be linked to an enduring reduction in anxiety and depression symptoms, according to a new study.

23 Feb 2023

Novel fatty liver organoid models could aid in drug discovery and testing

Researchers from the Organoid group (former Clevers group, Hubrecht Institute) together with researchers from the Princess Máxima Center for pediatric oncology established novel human organoid models of fatty liver disease.

23 Feb 2023

Researchers reveal the impact of vibrating capsules in chronic constipation patients

A new study in Gastroenterology aimed to analyze the safety and efficacy of oral administration of the vibrating capsule in chronic constipation patients.

23 Feb 2023

Study identifies a potential new targeted drug for treating acute myeloid leukemia

Targeted drugs have been developed to supplement chemotherapy in the treatment of cancer. These drugs only affect cancer cells, leaving healthy cells alone.

23 Feb 2023

Hormone replacement therapy for gender dysphoria may increase risk of serious cardiac events

People with gender dysphoria taking hormone replacements as part of gender affirmation therapy face a substantially increased risk of serious cardiac events, including stroke, heart attack and pulmonary embolism, according to a study presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.

23 Feb 2023

Pathogenicity of SARS-CoV-2 viral components on human periodontal tissues and cells

Researchers assessed the impact of COVID-19 on fibrotic pathogenesis via the deregulation of mitochondrial beta-oxidation.

23 Feb 2023

Minimally invasive focused ultrasound treatment improves symptoms in patients with Parkinson's disease

Patients with Parkinson's disease achieved a significant improvement in their tremors, mobility, and other physical symptoms after having a minimally invasive procedure involving focused ultrasound, according to a new study today published in the New England Journal of Medicine.

23 Feb 2023

Two newer simplified HIV treatment options found to be at least as effective as the standard of care

Two newer simplified treatment options are at least as effective as current approaches, according to the results of a world-first international clinical trial into second-line HIV therapy led by the Kirby Institute at UNSW Sydney and presented today at the Conference on Retroviruses and Opportunistic Infections in Seattle.

23 Feb 2023

Certain wearable gadgets could pose serious risks for people with cardiac implantable electronic devices

In recent years, wearable devices such as smartwatches and rings, as well as smart scales, have become ubiquitous – "must-haves" for the health conscious to self-monitor heart rate, blood pressure, and other vital signs.

23 Feb 2023

First-of-its-kind wireless, battery-free bandage accelerates wound healing

Northwestern University researchers have developed a first-of-its-kind small, flexible, stretchable bandage that accelerates healing by delivering electrotherapy directly to the wound site.

22 Feb 2023

Safety of a gene therapy to treat alpha 1-antitrypsin deficiency

Researchers report on the safety of a gene therapy to treat the common autosomal recessive hereditary disorder alpha 1-antitrypsin (AAT) deficiency in a new article in the peer-reviewed journal Human Gene Therapy.

22 Feb 2023

First phase I trial of intravenous mistletoe extract to treat advanced cancer

Mistletoe extract has been widely used to support cancer therapy and improve quality of life, but there has been a lack of clinical trials and data to support its use.

22 Feb 2023

First clinical trial of GABA/GAD focused exclusively on children with recent onset Type 1 diabetes

For the first time, humans with newly diagnosed Type 1 diabetes, or T1D, have received two treatments called GABA and GAD that have shown promise in animal studies and in isolated human pancreas islets. This investigator-initiated clinical trial, published in Nature Communications, focused exclusively on children with recent onset T1D.

22 Feb 2023

Therapy News and Research

Digital cognitive behavioral therapy reduces blood sugar levels in patients with diabetes

Exploring the immunomodulatory and anti-inflammatory properties of butyrate

A network of interacting proteins created to aid drug discovery

Study of adult e-cigarette users' attempts and experiences of quitting

Mystical and insightful psychedelic experience may be linked to positive mental health outcomes

Novel fatty liver organoid models could aid in drug discovery and testing

Researchers reveal the impact of vibrating capsules in chronic constipation patients

Study identifies a potential new targeted drug for treating acute myeloid leukemia

Hormone replacement therapy for gender dysphoria may increase risk of serious cardiac events

Pathogenicity of SARS-CoV-2 viral components on human periodontal tissues and cells

Minimally invasive focused ultrasound treatment improves symptoms in patients with Parkinson's disease

Two newer simplified HIV treatment options found to be at least as effective as the standard of care

Certain wearable gadgets could pose serious risks for people with cardiac implantable electronic devices

First-of-its-kind wireless, battery-free bandage accelerates wound healing

Safety of a gene therapy to treat alpha 1-antitrypsin deficiency

First phase I trial of intravenous mistletoe extract to treat advanced cancer

First clinical trial of GABA/GAD focused exclusively on children with recent onset Type 1 diabetes

First smart wearable device tracks how much people use their voices

Specific group of COVID-19 patients benefits the most from remdesivir, new analysis shows

New analysis shows how convalescent plasma can be used as effective, low-cost COVID-19 treatment

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News